Ernexa Therapeutics Inc. (ERNA) Total liabilities 2015–2025
Ernexa Therapeutics Inc. (ERNA) total liabilities at each fiscal year-end, per SEC filings.
$3.6MFY2025 · since FY2015: $11.3M → $3.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.6M | -92.4% |
| FY2024 | $46.9M | +361.1% |
| FY2023 | $10.2M | — |
| FY2021 | $5.2M | -41.9% |
| FY2020 | $9.0M | +13.7% |
| FY2019 | $7.9M | -28.0% |
| FY2018 | $11.0M | -12.6% |
| FY2017 | $12.6M | +0.5% |
| FY2016 | $12.6M | +10.7% |
| FY2015 | $11.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice